Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DKW80C
|
|||
| Drug Name |
GS-5894
|
|||
| Synonyms |
2,4-Dichloro-5-iodopyrimidine; 13544-44-0; 2, 4-dichloro-5-iodopyrimidine; 5-iodo-2,4-dichloropyrimidine; MFCD01898087; 2,4-Dichloro-5-iodo-pyrimidine; NSC97872; NCIOpen2_006533; 2,4-Chloro-5-iodopyrimidine; SCHEMBL117265; 5-iodo-2, 4-dichloropyrimidine; DTXSID90294754; RGJNPJRAXMSHKN-UHFFFAOYSA-N; BCP22998; NSC 97872; NSC-97872; AKOS002665245; 2,4-Dichloro-5-iodopyrimidine, 95%; AB10498; AC-1289; CS-W002862; GS-5894; SY009554; AM20080261; D4122; FT-0602319; EN300-252921; W-201138; Z1269214376
Click to Show/Hide
|
|||
| Drug Type |
Small molecule
|
|||
| Indication | Human immunodeficiency virus-1 infection [ICD-11: 1C62; ICD-10: B20-B24; ICD-9: 42] | Phase 1 | [1] | |
| Company |
Gilead
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C4HCl2IN2
|
|||
| Canonical SMILES |
C1=C(C(=NC(=N1)Cl)Cl)I
|
|||
| InChI |
InChI=1S/C4HCl2IN2/c5-3-2(7)1-8-4(6)9-3/h1H
|
|||
| InChIKey |
RGJNPJRAXMSHKN-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05585307) An Umbrella Phase 1b, Open-label, Multi-Cohort Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Novel Antiretrovirals in Participants With HIV-1. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.